Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




DiA and Edan Instruments Collaborate to Offer AI-Based Cardiac Ultrasound Solutions

By HospiMedica International staff writers
Posted on 10 Sep 2019
DiA Imaging Analysis Ltd. More...
{(DiA) Be'er Sheva, Israel}, a provider of artificial intelligence (AI)-powered ultrasound analysis solutions, has entered into a partnership with Edan Instruments Inc. (Shenzen, China), a medical products and services company, to offer DiA's AI-based cardiac analysis solutions as an integrated part of Edan's ultrasound devices.

DiA uses advanced AI-based technology to assist clinicians at all levels of experience to acquire and analyze ultrasound images – objectively and accurately, improving patient management. DiA's solutions are cross-platform that can be easily implemented to ultrasound devices and healthcare IT systems, as an integrated part of clinician's workflow. DiA's AI-based cardiac solution, LVivo Toolbox, provides a fast and objective cardiac ultrasound analysis that assists in reducing the subjectivity and increasing the efficiency of clinician's decision-making process. LVivo Toolbox can be easily used by clinicians with various levels of experience and fits to operate as an integrated add-on solution on ultrasound devices and Healthcare IT systems.

Edan is a healthcare company engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. Edan has developed unique ultrasound devices that offer advanced imaging technologies, dual touch screens and a gesture-control user interface, supporting a wide range of clinical applications and delivering excellent image clarity.

"Edan provides innovative and high-quality medical products and services, bringing the most ground-breaking imaging technologies to its customers that best fit their clinical setting and needs," said Renfu Zhang, Edan's ultrasound product line director. "With DiA's AI-based cardiac solution, we will offer our customers an additional layer of automated AI-based analysis, as part of their everyday workflow."

"We are thrilled to partner with Edan Instruments and join forces to offer Edan's customers objective and fast clinical indications that they often struggle to find visually," said Hila Goldman Aslan, DiA's CEO and co-founder.

Related Links:
DiA Imaging Analysis
Edan Instruments


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Cardiograph Device
PageWriter TC35
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.